<p>CLOUDR (09955.HK) announced its full-year results for the year ended last December, with revenue of RMB 1.623 billion, a year-on-year decrease of 53.5%. Losses widened to RMB 924 million, compared to a loss of RMB 516 million in the same period last year; loss per share was RMB 1.52. No dividend was declared</p>

159929

512010

510660

513120

09955

516610

<p>CLOUDR announced its full-year results for the year ended December last year, with a revenue of RMB 1.623 billion, a year-on-year decrease of 53.5%. The loss widened to RMB 924 million, compared to a loss of RMB 516 million in the same period last year; the loss per share was RMB 1.52. No dividend was declared</p>

AASTOCKS

China Universal 800 Health Care ETF

E Fund CSI 300 Health Care ETF

ChinaAMC SSE Health Care ETF Initiating Fund

GF CSI HK Innovative Drugs Industry ETF(QDII)

CLOUDR

Dacheng CSI All Share Health Care Equipment and Services ETF

In the performance report, CLOUDR's annual loss widened to 924 million yuan